Winning Global Customers through Innovative Quality Pharmaceutical Products

» Ind-Swift Chalks Out Ambitious Over $ 20 Million Expansion Plan
» Ind-Swift Laboratories Limited undergoes successful USFDA audit

Ind-Swift files DMF for Donepezil Hydrochloride and Nateglinide

Ind Swift Labs Ltd. has recently filed two DMFs with USFDA for Donepezil Hydrochloride and Nateglinide. The company has already filed more than 10 DMFs and plans to file 4-5 DMFs each year.